GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio Plus Co Ltd (XKRX:099430) » Definitions » EV-to-FCF

Bio Plus Co (XKRX:099430) EV-to-FCF : -13.94 (As of Jun. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Bio Plus Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bio Plus Co's Enterprise Value is ₩235,672 Mil. Bio Plus Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-16,904 Mil. Therefore, Bio Plus Co's EV-to-FCF for today is -13.94.

The historical rank and industry rank for Bio Plus Co's EV-to-FCF or its related term are showing as below:

XKRX:099430' s EV-to-FCF Range Over the Past 10 Years
Min: -409.67   Med: -63.64   Max: 180.47
Current: -13.94

During the past 6 years, the highest EV-to-FCF of Bio Plus Co was 180.47. The lowest was -409.67. And the median was -63.64.

XKRX:099430's EV-to-FCF is ranked worse than
100% of 359 companies
in the Medical Devices & Instruments industry
Industry Median: 26.21 vs XKRX:099430: -13.94

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-23), Bio Plus Co's stock price is ₩5080.00. Bio Plus Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩370.000. Therefore, Bio Plus Co's PE Ratio for today is 13.73.


Bio Plus Co EV-to-FCF Historical Data

The historical data trend for Bio Plus Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio Plus Co EV-to-FCF Chart

Bio Plus Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-FCF
Get a 7-Day Free Trial - - - -173.69 48.86

Bio Plus Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.02 -161.86 176.25 -61.57 -20.56

Competitive Comparison of Bio Plus Co's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Bio Plus Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio Plus Co's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio Plus Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Bio Plus Co's EV-to-FCF falls into.



Bio Plus Co EV-to-FCF Calculation

Bio Plus Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=235672.250/-16904.227
=-13.94

Bio Plus Co's current Enterprise Value is ₩235,672 Mil.
Bio Plus Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-16,904 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio Plus Co  (XKRX:099430) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bio Plus Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5080.00/370.000
=13.73

Bio Plus Co's share price for today is ₩5080.00.
Bio Plus Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩370.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Bio Plus Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Bio Plus Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio Plus Co (XKRX:099430) Business Description

Traded in Other Exchanges
N/A
Address
Sagimakgol-ro 45th Street 14, Seongnam Woolim Lions Valley 2cha A-dong 180, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR
Bio Plus Co Ltd is engaged in the development of innovative biomedical and medical devices products through research on bio-material applications platform technology.

Bio Plus Co (XKRX:099430) Headlines

No Headlines